top of page
  • substack_logo_icon_249485
  • apple-podcast-icon-audio-streaming-symbol-digital-content-concept-vector
  • Spotify
  • Instagram
  • Youtube
  • TikTok
  • LinkedIn

The pill for PCOS: How to decide what’s right for you

  • Writer: Dr Natalie Hutchins
    Dr Natalie Hutchins
  • 14 hours ago
  • 7 min read

By Eleanor Riches and Dr Natalie Hutchins


PCOS and the pill

If you have PCOS, chances are the pill came up early in your care.


For some women, it’s genuinely helpful; periods become more predictable, skin settles, and symptoms feel easier to manage. For others, it doesn’t feel right, or it raises more questions than it answers.


What’s often missing from these conversations is nuance. The pill is sometimes treated as a default solution, and sometimes dismissed altogether. In reality, it’s neither. The pill can be a useful tool when it’s prescribed to the right person for the right reasons, but it isn’t one-size-fits-all.


This article looks at what the science actually says about PCOS and the pill; what it does well, where its limits are, and how to think about it as part of personalised care.


Why the pill is recommended for PCOS

According to the 2023 International PCOS Guidelines, combined oral contraceptive pills (often shortened to COCPs) are recommended as a first-line treatment for women with PCOS who are not trying to conceive.1 


This isn’t because the pill “cures” PCOS (it doesn’t), but it does help manage some of the most common and disruptive symptoms.


The pill is most commonly offered to women experiencing:

●      Irregular or absent periods, usually caused by disrupted ovulation

●      Acne or excess hair growth, driven by higher androgen levels

●      A need for reliable contraception, alongside uterine lining protection


For many women with PCOS, these symptoms are what impact their day-to-day life and push them to seek support.


What the pill actually does in PCOS

Combined pills contain two hormones: oestrogen and a progestin (a synthetic form of progesterone). Together, they override the body’s natural hormonal fluctuations, which are led by egg development and ovulation each month. By providing a constant dose of synthetic hormones, the pill creates a controlled, predictable pattern.2 


In practical terms, the pill works in several ways:

  1. It pauses ovulation

The pill suppresses the hormonal signals that trigger egg development and ovulation each month. Since this process tends to happen irregularly in women with PCOS, the pill can reduce the unpredictable hormone spikes that contribute to acne, hair growth and cycle disruption.3


  1. It lowers androgen production in the ovaries

In PCOS, the ovaries are often overstimulated to produce higher levels of androgens, like testosterone. By suppressing ovulation-related signals, the pill reduces ovarian androgen production.4 Over time, lower androgen levels can lead to:

-        Fewer acne breakouts

-        Slower or reduced facial and body hair growth

-        Less scalp hair thinning in some women


  1. It increases sex hormone-binding globulin (SHBG)

SHBG is a protein made by the liver. It acts like a sponge, binding to testosterone in the bloodstream. When more testosterone is bound by SHBG, less is free and “active”, which reduces its impact on the skin and hair follicles. This is one of the main reasons the pill improves androgen-related symptoms.3


  1. It protects against uterine cancer

The monthly bleed on the pill isn’t a natural period; it’s called a withdrawal bleed, triggered by the temporary drop in hormones during the pill-free interval. Even though it isn’t a true menstrual cycle, this regular shedding of the uterine lining protects long-term health by reducing the risk of cancer.3 


Why cycle regulation matters in PCOS

Research consistently shows that cycle regulation is one of the pill’s most reliable benefits in PCOS.5 

This matters for more than convenience. Long gaps between periods aren’t just frustrating or unpredictable – they can carry long-term health problems. Prolonged exposure to oestrogen without regular shedding can cause the endometrium to thicken and increase the risk of cancer.


By providing predictable bleeding, the pill helps reduce this risk and offers important long-term protection – particularly for women who aren’t menstruating regularly.3 


What the research shows so far

When researchers study how the pill works in women with PCOS (rather than assuming it behaves in the same way as in the general population), some clear patterns start to emerge.


A 2023 systematic review comparing women with PCOS who took the pill with those who received no medical treatment found strong evidence that the pill improves cycle regulation in PCOS.5


For other outcomes, however, the evidence was much less clear. The review found very low-certainty evidence for improvements in:

●      Hirsutism (excess facial or body hair)

●      Body weight and BMI

●      Quality of life measures


This doesn’t mean the pill can’t help with these symptoms. It means the existing studies aren’t strong enough to give us clear, long-term answers, and more PCOS-specific research is needed.


Most PCOS-specific trials are small, short-term and use different pill formulations. Plus, PCOS itself is highly individual, which makes it harder for research to capture meaningful change across groups. Many women do report improvements in skin, hair, or overall symptoms over time, but these effects aren’t always reflected in research.


The takeaway is clear: the pill works reliably for cycle regulation, but its effects on other PCOS symptoms are more personalised.


Does the type of pill matter?

Yes. And this is where individualised care really matters.


Not all combined oral contraceptive pills are the same. In fact, there’s a lot to choose from. Different formulations contain different types and doses of oestrogen and progestin. These differences affect how the pill behaves in the body, particularly in women with PCOS.6 


In broad terms, pill formulations can vary in:

●      Oestrogen dose, which influences clotting risk and metabolic effects.

●      Type of progestin, which can have more androgenic (testosterone-like) or anti-androgenic effects.

●      Overall metabolic and cardiovascular risk, especially in women with insulin resistance or higher BMI.


A large review comparing different pill formulations in women with PCOS6 found that:

●      Pills with anti-androgenic progestins (such as cyproterone acetate or drospirenone) were more effective at reducing testosterone levels.

●      Lower-dose oestrogen pills offered similar PCOS symptom control to higher doses, with a lower risk of blood clots.

●      Formulations with stronger androgen suppression were linked to higher clotting risk and are no longer recommended as first-line options.


This balance between benefit and risk is a central theme throughout PCOS care. More androgen suppression isn’t always better if it comes with more long-term risk.


Why there’s no “best pill” for PCOS

Recent research shows that PCOS isn’t one single condition. It’s a spectrum of different biological patterns, often described as “subtypes”.7 This concept helps explain why PCOS can look completely different from person to person, and why the pill can be genuinely helpful for some women, but less effective for others.6


How the pill works for different PCOS subtypes:

●      Androgen-driven PCOS

When excess androgens are the main driver, the pill can help reduce androgen production in the ovaries and increase sex hormone-binding globulin. This can help with androgen-driven symptoms like acne, excess hair growth, and irregular bleeding.


●      Insulin-resistant PCOS

The pill can help provide predictable bleeding and hormonal stability, but its impact on metabolic symptoms tends to be limited. For this subtype, outcomes tend to be better when the pill is used alongside lifestyle changes or treatments to improve insulin sensitivity.


●      PCOS driven by neuroendocrine disruption:

In this subtype, disrupted signalling between the brain and ovaries can lead to irregular cycles and fluctuating hormones. The pill can suppress irregular signalling and create stability, but it doesn’t fix the underlying communication pattern, which is why some symptoms improve while others don’t.


Because PCOS can have different starting points and drivers, international guidelines avoid recommending a single “best pill” for PCOS.1 Instead, they emphasise taking a personalised approach that looks at:

  1. Metabolic health, including insulin sensitivity and cardiovascular risk

  2. Symptom priorities, such as skin concerns, bleeding regularity, or contraception

  3. Personal risk factors, like BMI, smoking status, or clotting history

  4. How your body responds to the pill over time, with room to review and adjust treatment


The goal isn’t to find the strongest pill or the “right” one for PCOS, it’s to find the option that best supports your body, symptoms and health goals at that specific point in your life.


What if you don’t want to take the pill?

The pill is an effective option for managing PCOS, but it’s not the only one. If you don’t want to take the pill, other evidence-based approaches can help support PCOS.


These might include:

●      Lifestyle changes: Small, sustainable changes to diet, movement, sleep and stress to improve insulin sensitivity are a first-line treatment for PCOS.8  

●      Metformin: A medication for metabolic support, particularly prescribed when PCOS is linked to insulin resistance or metabolic risk.9 

●      Ovulation-induction medications: When fertility is the priority, medications like letrozole or clomiphene can help stimulate ovulation.10 

●      Anti-androgen medications: For persistent skin or hair symptoms, medications like spironolactone can reduce the effects of androgens.11 

●      Non-oral contraceptives or IUDs: These options can protect the uterine lining and provide contraception without the systemic hormone effects of the pill.12


Making sense of the evidence

The research shows that the pill can be a useful, evidence-based option for many women with PCOS; especially for regulating periods, reducing androgen-related symptoms and protecting the uterine lining.

These are real, science-backed benefits, which can make a meaningful difference in day-to-day life.


But the pill doesn’t address every aspect of PCOS on its own. PCOS is a whole-body condition involving hormones, metabolism and brain-ovary signalling, which means no single treatment can tackle everything.


How well the pill works (and how it feels) depends on several factors. This includes the type of pill, how PCOS shows up in your body, your metabolic health, and what you most want support with right now.


This is exactly why current guidelines move away from one-size-fits-all treatment and instead focus on personalised PCOS care. The most effective PCOS management happens when decisions are made collaboratively, reviewed over time and adjusted to fit your needs.


Sources

  1. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

  2. NHS: Combined pill

  3. An Update on Contraception in Polycystic Ovary Syndrome

  4. Pharmacological management of polycystic ovary syndrome

  5. Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: A systematic review

  6. Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis

  7. Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomes

  8. The Role of Lifestyle Interventions in PCOS Management: A Systematic Review

  9. The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials

  10. Effects of letrozole combined with clomiphene in the treatment of polycystic ovary syndrome: a meta-analysis

  11. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials

  12. The hormonal contraceptive choice in women with polycystic ovary syndrome and metabolic syndrome


bottom of page